Immunotherapy Using a Logical AND Combination for Immune Response Activation

A method comprising:

• administering a first medication to a patient, wherein the first medication includes a first molecule and a second molecule, wherein the first molecule includes a first antibody and a first dock, and wherein the second molecule includes a second antibody and a second dock;
• after the elapse of a first predetermined interval, administering a glue molecule to the patient, wherein the glue molecule binds to both the first dock and the second dock, and wherein a structured binding site is formed when the glue molecule is simultaneously bound to both the first dock and the second dock;
• and
• after the elapse of a second predetermined interval, administreing a binding molecule to the patient, wherein the binding molecule binds only to the structured binding site and activates immune cells of the patient.

A method comprising:

• generating image objects from a digital image of tissue from a cancer patient;
• determining that the image objects are cells that have been stained with both a first biomarker and a second biomarker;
• and
• administering an AND molecule to the cancer patient, wherein the AND molecule includes a first antibody and a second antibody, wherein the second antibody has a shape that can bind to its corresponding antigen only when the first antibody is bound to its corresponding antigen, and wherein the AND molecule includes a binding site that can bind to immune cells only when both the first antibody and the second antibody are bound to their corresponding antigens.